港股異動 | 滔搏(6110.HK)漲逾5%再創新高 此前獲大摩唱好
格隆匯1月4日丨滔搏(6110.HK)股價繼續走強,盤中最高見12.3港元再創新高,現報12.22港元,漲幅5.34%,最新總市值757.8億;該股去年累計上漲32%。大摩研報指,相信市場對潛在配股的擔憂已反映在近日股價上。考慮到滔博2021下半財年至2022上半財年將實現強勁的銷售和盈利提升,並繼續受惠於內地運動服裝行業的結構性增長,相信未來6至12個月內將產生良好回報,予“增持”評級,目標價13.1港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.